Moncton Hospital - Horizon Health Network ( Site 0055)

Moncton, New Brunswick E1C 6Z8

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Merkel Cell Carcinoma

Studies at this site

• Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913) — Completed
• Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716) — Running, not enrolling